WASHINGTON TRUST Co boosted its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 33.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 870 shares of the company’s stock after purchasing an additional 220 shares during the quarter. WASHINGTON TRUST Co’s holdings in Clorox were worth $119,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC lifted its position in shares of Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after acquiring an additional 145 shares during the period. Northwest Financial Advisors bought a new position in Clorox during the fourth quarter worth about $29,000. Core Wealth Advisors Inc. acquired a new stake in shares of Clorox in the 4th quarter valued at about $29,000. First United Bank & Trust acquired a new position in Clorox during the fourth quarter worth approximately $31,000. Finally, GoalVest Advisory LLC acquired a new position in Clorox during the first quarter worth approximately $31,000. Institutional investors own 78.53% of the company’s stock.
Clorox Stock Up 1.2 %
CLX traded up $1.75 during midday trading on Tuesday, reaching $143.54. The company’s stock had a trading volume of 571,496 shares, compared to its average volume of 1,262,243. The stock’s 50-day moving average is $135.47 and its 200-day moving average is $142.40. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $162.43. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The firm has a market capitalization of $17.83 billion, a price-to-earnings ratio of 73.47, a PEG ratio of 1.97 and a beta of 0.39.
Clorox Increases Dividend
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on the company. DA Davidson cut their price target on Clorox from $162.00 to $153.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 target price for the company. Argus upgraded Clorox to a “hold” rating in a research note on Tuesday, June 4th. Citigroup cut their target price on Clorox from $150.00 to $145.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. Finally, UBS Group cut their target price on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Six research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $141.94.
View Our Latest Research Report on Clorox
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Investing In Preferred Stock vs. Common Stock
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- What is the Euro STOXX 50 Index?
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.